CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • CICON17 Day 3 Recap: Combinations, Checkpoint Immunotherapy Resistance, Immunomodulators, and Microbiota

    Day 3 of the CICON17 focused on combination therapies, immunomodulators, overcoming immune suppression, and the role bacteria in…

    September 9, 2017| Arthur N. Brodsky, PhD
  • CICON17 Day 1 Recap: Neoantigens, Vaccines, and Overcoming Immunotherapy Resistance

    Day 1 of CICON17 explored how to identify and target neoantigens with vaccines and other strategies to…

    September 7, 2017| Arthur N. Brodsky, PhD
  • Highlights of the 2nd Annual Rational Combinations 360° Conference

    Biomarkers will be crucial to taking advantage of combination immunotherapy’s full potential

    August 11, 2017| Arthur N. Brodsky, PhD
  • ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference

    ASCO17’s presentations reveal that the field of immunotherapy is advancing along many fronts

    June 16, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Days 4 and 5 Immunotherapy Highlights

    Days 4 and 5 at ASCO17 showed off the overall scope of immunotherapy’s efforts to provide clinical…

    June 6, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Day 3 Immunotherapy Highlights

    Day 3 at the 2017 annual meeting of the American Society of Clinical Oncology touched on immunotherapy…

    June 5, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Day 2 Immunotherapy Highlights

    Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's…

    June 4, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Day 1 Immunotherapy Highlights

    Day 1 at the 2017 annual meeting of the American Society of Clinical Oncology demonstrated immunotherapy’s potential…

    June 3, 2017| Arthur N. Brodsky, PhD
  • ASCO17: Exploring the Past, Present, and Future of Immunotherapy

    Immunotherapy is poised to shine at ASCO17

    June 1, 2017| Arthur N. Brodsky, PhD
Previous Page
1 … 6 7 8 9 10 … 15
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute